India and management of COVID-19: A case study on published guidelines

Drug Discov Ther. 2021 Sep 22;15(4):171-179. doi: 10.5582/ddt.2021.01054. Epub 2021 Aug 26.


In the face of the ongoing pandemic, the primary care physicians in India are dealing not only with an increased number of patients but are also facing difficulties in the management of complex critically ill patients. To guide the management plans of primary care physicians, several guidelines have been published by the central and state health bodies. In such a situation, an updated and unifying state, national and international guidelines based on critical analysis and appraisal of evolving data is the need of the hour. In this review, we critically analysed the current existing guidelines that have been formulated within India in light of recent evidence.

Keywords: Coronavirus disease 2019; SARS-CoV-2; antiviral.

MeSH terms

  • COVID-19 / classification
  • COVID-19 / drug therapy*
  • COVID-19 / mortality
  • Clinical Trials as Topic
  • Disease Management
  • Humans
  • India
  • Practice Guidelines as Topic
  • Severity of Illness Index
  • Survival Analysis
  • Treatment Outcome

Supplementary concepts

  • COVID-19 drug treatment